Zacks Investment Research
12 May 2026, 14:41 UTC · 22w ago
Verdict
Headline leans bearish. We score ICCM −0.90 across three claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−0.90strongly bearish
More negative than 90% of ticker scores this week
Top 1 mover · tap to explore
What the story claims
3 claims · scored −1 bearish … +1 bullish
IceCure Medical (ICCM) reported a quarterly loss of $0.06 per share, missing the Zacks Consensus Estimate of a $0.03 loss.
So whatAn earnings miss of -100% relative to expectations typically triggers immediate downward pressure on a stock's price.
More negative than 94% of claims this week
IceCure Medical's quarterly revenues of $0.91 million missed the Zacks Consensus Estimate by 54.9%.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
More negative than 89% of claims this week
IceCure Medical has failed to beat consensus EPS and revenue estimates for four consecutive quarters.
So whatA consistent pattern of misses indicates systemic underperformance, eroding investor confidence in management's guidance.
More negative than 84% of claims this week
Which stocks this story touches
More negative than 90% of ticker scores this week
The company reported a larger than expected quarterly loss, missed revenue estimates by 54.9%, and has failed to beat consensus estimates for four consecutive quarters.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
2h ago
Investopedia
32m ago
−85.1%
Price agrees with the score
$1.07 vs $7.20 close before publication (May 11) · not market-adjusted
ICCM chart →
